Impact of gastroesophageal reflux control through tailored proton pump inhibition therapy or fundoplication in patients with Barrett’s esophagus

doi:10.3748/wjg.v23.i17.3174

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 17

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7287)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-2) series.

Item

Count

PDF

613

WORD

319

HTML

3695

Figures (1-5)

199

Tables (1-2)

150

Sum=4976

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

887

Download

1424

Sum=2311

May 7, 2017 (publication date) through Jul 6, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

World J Gastroenterol. May 7, 2017; 23(17): 3174-3183
Published online May 7, 2017. doi: 10.3748/wjg.v23.i17.3174

Full Size Figure Download Figure

Figure 3 Gastroesophageal reflux disease-health related quality of life scores in patients with Barrett’s esophagus at baseline and after increasing doses of proton pump inhibitor in the non-operated (group 1) and after anti-reflux surgery (group 2). Group 2 was subdivided into those with and without normal acid reflux. Medians, 25%-75% quartiles and 10%-90% ranges. GERD/HRQL: Gastroesophageal reflux disease-health related quality of life.

Citation: Baldaque-Silva F, Vieth M, Debel M, Håkanson B, Thorell A, Lunet N, Song H, Mascarenhas-Saraiva M, Pereira G, Lundell L, Marschall HU. Impact of gastroesophageal reflux control through tailored proton pump inhibition therapy or fundoplication in patients with Barrett’s esophagus. World J Gastroenterol 2017; 23(17): 3174-3183
URL: https://www.wjgnet.com/1007-9327/full/v23/i17/3174.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i17.3174